This document contains a financial statement as of April 2, 2014, detailing the holdings and unrealized gains/losses of various biotech stocks, including Sangamo Biosciences, Biogen, Foundation Medicine, Gilead Sciences Inc, and Ariad Pharmaceuticals. It also includes a one-month price history for Sangamo Biosciences.
documents/vol00010-efta01461594-pdf.pdf
{"document_date":"2014-04-02","document_type":"tabular","document_subtype":"financial statement","key_organizations":["Sangamo Biosciences","Biogen","Foundation Medicine","Gilead Sciences Inc","Ariad Pharmaceuticals"],"reference_numbers":["DB-SDNY-0123736","SDNY_GM_00269920","EFTA01461594"]}